background image

Paid Clinical Trials Lexington

Discover 459 paid clinical trials in Lexington, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Dato-DXd & Rilvegostomig

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Lexington, Cincinnati, Knoxville, Nashvilleshow 68 more

Code:

NCT06564844

Conditions

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Datopotamab Deruxtecan

Rilvegostomig

Carboplatin

Cisplatin

Etoposide

Neuroblastoma

Recruiting
PHASE2

Sponsor:

Giselle Sholler

Location:

Lexington, Louisville, Columbus, Nashvilleshow 42 more

Code:

NCT02679144

Conditions

Neuroblastoma

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Difluoromethylornithine (DFMO)

Observational Study

Recruiting

Sponsor:

Children's Oncology Group

Location:

Lexington, Louisville, Cincinnati, Huntingtonshow 167 more

Code:

NCT02402244

Conditions

Adrenal Gland Pheochromocytoma

Carcinoma In Situ

Central Nervous System Neoplasm

Childhood Immature Teratoma

Childhood Langerhans Cell Histiocytosis

Eligibility Criteria

Sex: All

Age: 0 - 25

Healthy Volunteers: Not accepted

Interventions

Cytology Specimen Collection Procedure

Medical Chart Review

BMF-500

Recruiting
PHASE1

Sponsor:

Biomea Fusion Inc.

Location:

Lexington, Cleveland, Atlanta, Chicagoshow 18 more

Code:

NCT05918692

Conditions

Acute Myeloid Leukemia

Acute Lymphoblastic Leukemia

Acute Mixed-Phenotype Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMF-500

Adjuvant Chemotherapy

Recruiting

Sponsor:

Razor Genomics

Location:

Lexington, Louisville, Nashville, Ashevilleshow 16 more

Code:

NCT01817192

Conditions

Non-Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Adjuvant Chemotherapy

Radiographic surveillance

14-Gene Prognostic Assay

Bexotegrast

Recruiting
PHASE2

Sponsor:

Pliant Therapeutics, Inc.

Location:

Lexington, Louisville, Cincinnati, Knoxvilleshow 75 more

Code:

NCT06097260

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

PLN-74809

Placebo

Lomustine with Temozolomide & Radiation

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Lexington, Louisville, Franklin, Centervilleshow 254 more

Code:

NCT05095376

Conditions

Glioblastoma

Gliosarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lomustine

Photon Beam Radiation Therapy

Quality-of-Life Assessment

Questionnaire Administration

Temozolomide

Bromocriptine

Recruiting

Sponsor:

Dennis M. McNamara, MD, MS

Location:

Lexington, Indianapolis, Nashville, Charlotteshow 47 more

Code:

NCT05180773

Conditions

Peripartum Cardiomyopathy, Postpartum

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bromocriptine

Placebo

Guideline Directed Medical Therapy for Heart Failure (GDMT)

Rivaroxaban

Second Placebo

Baxdrostat & Dapagliflozin

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Lexington, Kingsport, Columbus, Evansvilleshow 122 more

Code:

NCT06268873

Conditions

Chronic Kidney Disease and Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Baxdrostat/dapagliflozin

Dapagliflozin in combination with placebo

FF-10832 & Pembrolizumab

Recruiting
PHASE2

Sponsor:

Fujifilm Pharmaceuticals U.S.A., Inc.

Location:

Lexington, Louisville, Cincinnati, Nashvilleshow 16 more

Code:

NCT05318573

Conditions

Advanced Urothelial Carcinoma

Advanced Non Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

FF-10832